Management guidelines and outcome measures in giant cell arteritis (GCA)

被引：0

作者：

Warrington, K. J. ^{[1
]}

Matteson, E. L. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2007年 / 25卷 / 06期

关键词：

vasculitis; giant cell arteritis; polymyalgia rheumatica; headache; corticosteroids; aneursym;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the condition and the diagnosis is usually established by temporal artery biopsy. Corticosteroids are the mainstay of treatment for GCA and prolonged therapy is often necessary. Disease relapses and steroid-related adverse effects, however, are common. Serious complications of the disease may include visual loss, stroke, and aortic involvement with aneurysm formation.

引用

页码：S137 / S141

页数：5

共 35 条

[1] HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS
ACHKAR, AA
LIE, JT
HUNDER, GG
OFALLON, WM
GABRIEL, SE
[J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 987 - 992
[2] Treatment of refractory temporal arteritis with adalimumab
Ahmed, M. Mubashir
Mubashir, Eisha
Hayat, Samina
Fowler, Marjorie
Berney, Seth Mark
[J]. CLINICAL RHEUMATOLOGY, 2007, 26 (08) : 1353 - 1355
[3] TREATMENT OF TEMPORAL ARTERITIS WITH ADRENAL CORTICOSTEROIDS - RESULTS IN 55 CASES IN WHICH LESION WAS PROVED AT BIOPSY
BIRKHEAD, NC
WAGENER, HP
SHICK, RM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 163 (10): : 821 - 827
[4] Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging
Bley, TA
Weiben, O
Uhl, M
Vaith, P
Schmidt, D
Warnatz, K
Langer, A
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2470 - 2477
[5] Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis:: A prospective study of 35 patients
Blockmans, D
De Ceuninck, L
Vanderschueren, S
Knockaert, D
Mortelmans, L
Bobbaers, H
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (01): : 131 - 137
[6] Large-vessel involvement in giant cell arteritis
Bongartz, T
Matteson, EL
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (01) : 10 - 17
[7] Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO
[8] 2-Y
[9] Steroid management in giant cell arteritis
Chan, CCK
Paine, M
O'Day, J
[J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (09) : 1061 - 1064
[10] AZATHIOPRINE IN GIANT-CELL ARTERITIS POLYMYALGIA RHEUMATICA - A DOUBLE-BLIND-STUDY
DESILVA, M
HAZLEMAN, BL
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (02) : 136 - 138

← 1 2 3 4 →